Exploratory outcome analyses according to stage and/or residual disease in the ICON7 trial of carboplatin and paclitaxel with or without bevacizumab for newly diagnosed ovarian cancer

  1. González Martín, A.
  2. Oza, A.M.
  3. Embleton, A.C.
  4. Pfisterer, J.
  5. Ledermann, J.A.
  6. Pujade-Lauraine, E.
  7. Kristensen, G.
  8. Bertrand, M.A.
  9. Beale, P.
  10. Cervantes, A.
  11. Kent, E.
  12. Kaplan, R.S.
  13. Parmar, M.K.B.
  14. Scotto, N.
  15. Perren, T.J.
Revista:
Gynecologic Oncology

ISSN: 1095-6859,  0090-8258

Ano de publicación: 2019

Volume: 152

Número: 1

Páxinas: 53-60

Tipo: Artigo

DOI: 10.1016/J.YGYNO.2018.08.036 GOOGLE SCHOLAR lock_openAcceso aberto editor
Fonte de datos: Scopus